Souvenaid

Souvenaid is a medical food designed to support synaptic function in individuals with Alzheimer's disease. It is a product of the Nutricia company, a subsidiary of Danone. Souvenaid contains a unique combination of nutrients, known as Fortasyn Connect, which are intended to enhance synapse formation and function in the brain.

Composition

Souvenaid contains a patented combination of nutrients known as Fortasyn Connect. This includes omega-3 fatty acids, uridine monophosphate, choline, vitamins B6, B12, C, E, selenium, folic acid, and phospholipids. These nutrients are believed to support the formation of new synapses in the brain.

Clinical Trials

Several clinical trials have been conducted to evaluate the efficacy of Souvenaid. The LipiDiDiet trial, a two-year, multi-center, randomized, controlled trial, showed that Souvenaid slowed the progression of symptoms in early Alzheimer's disease. However, more research is needed to fully understand the long-term effects and potential benefits of Souvenaid.

Usage

Souvenaid is intended for use under medical supervision. It is not intended to replace normal diet or drug therapy. It is typically recommended for individuals in the early stages of Alzheimer's disease.

Side Effects

Common side effects of Souvenaid include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. These side effects are usually mild and temporary.

See Also

• Alzheimer's disease
• Nutricia
• Danone
• Clinical trial
• Omega-3 fatty acids
• Uridine monophosphate
• Choline
• Vitamins
• Phospholipids

References

<references />

This article is a stub related to pharmacology. You can help WikiMD by expanding it!